Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H2A.Z histone pseudogene 6 (H2AZP6) is a **non-protein-coding pseudogene** related to the H2A.Z histone variant. Unlike H2A.Z, which is a conserved and multifunctional histone variant essential for regulating chromatin structure, transcription, genome stability, and cell cycle, the pseudogene H2AZP6 has no known protein-coding function, biological role, or therapeutic relevance[1][2][5][6]. The functional H2A.Z protein is involved in multiple dynamic chromatin processes driven by post-translational modifications such as acetylation and ubiquitination, but H2AZP6 does not contribute directly to these processes.
Not applicable for H2AZP6. For the H2A.Z histone variant: post-translational modifications (PTMs), such as acetylation, methylation, ubiquitination, influence chromatin structure and gene regulation[2][6].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H2A.Z histone pseudogene 6 (H2AZP6).